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Abstract
Hyperkalemia is an important cause of membrane depolarization in renal failure. A recent theoretical model of axonal
excitability explains the effects of potassium on threshold electrotonus, but predicts changes in superexcitability in the
opposite direction to those observed. To resolve this contradiction we assessed the relationship between serum potassium
and motor axon excitability properties in 38 volunteers with normal potassium levels. Most threshold electrotonus measures
were strongly correlated with potassium, and superexcitability decreased at higher potassium levels (P= 0.016), contrary to
the existing model. Improved modelling of potassium effects was achieved by making the potassium currents obey the
constant-field theory, and by making the potassium permeabilities proportional to external potassium, as has been
observed in vitro. This new model also accounted well for the changes in superexcitability and other excitability measures
previously reported in renal failure. These results demonstrate the importance of taking potassium levels into account when
assessing axonal membrane dysfunction by excitability testing, and provide evidence that potassium currents are activated
by external potassium in vivo.
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Introduction
Nerve excitability tests [1,2] have been increasingly applied in
clinical neurophysiology to assess the excitability properties of
motor axons, and to infer likely underlying changes in membrane
properties (e.g. membrane potential and ion channel functions)[3–
6]. Recent clinical applications include prediction of survival in
amyotrophic lateral sclerosis [7] and early warning of chemother-
apy-induced neurotoxicity [8], but an early and continuing
contribution has been towards the understanding and possible
prevention of uraemic neuropathy. The pathophysiological basis
of uraemic neuropathy is not well understood, and unidentified
neurotoxic factors have been blamed, but nerve excitability studies
have provided evidence that peripheral nerves are chronically
depolarized in renal failure, due to hyperkalemia which is only
temporarily relieved by dialysis [9–13]. This has led to the
hypothesis that hyperkalemic depolarization may be an underes-
timated cause of neuropathy in chronic renal failure [14] and to
attempts to prevent the development of neuropathy by maintain-
ing normokalemia.
Despite the importance of potassium effects on peripheral nerve
and nerve excitability, the biophysical basis of these effects is only
partly understood. Since the resting potential depends primarily
on the selective permeability of the axolemma to potassium ions, it
is expected that hyperkalemia will cause membrane depolarization
with a consequent increase in potassium permeability and
membrane conductance, and thereby a ‘fanning-in’ of threshold
electrotonus. This behaviour is well accounted for by a model of
nerve excitability, in which myelinated axons are represented by
two linked compartments (node and internode), with different
assortments of ion channels following Hodgkin-Huxley equations
[3,15–17]. However this model, which predicts quite well the
effects of altering membrane potential by applied currents and the
effects of reducing different ion currents, does not account for the
effects of hyperkalemia on nerve excitability in end-stage kidney
disease (ESKD)[13]. Arnold et al. found that the excitability
abnormalities in ESKD patients were ‘profoundly worse than that
expected for normal axons exposed to similarly high potassium
concentrations’. Moreover, whereas superexcitability in the ESKD
patients falls steeply with increasing potassium, the model predicts
a slight increase [13], because of the reduction in the post-spike
hyperpolarization by slow potassium currents. Since their model-
ling suggested that nodal fast potassium conductance was
increased in the patients, Arnold et al. proposed that the
hyperkalaemia may have disrupted the paranodal myelin, thereby
exposing juxtaparanodal potassium channels. However, an alter-
native interpretation is that their results exposed a deficiency in the
modelling of the potassium channels.
There has only been one previous study exploring the
relationship between superexcitability and serum potassium in
normal subjects (n = 12), which found a significant relationship
(p = 0.02), again contradicting the model [18]. The present study
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e98262
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
63
39
5 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
was undertaken on a larger group of normal subjects, to define
more clearly the potassium dependence of superexcitability and
other excitability measures, to clarify any difference from the
relationship in uraemic patients, and to improve the model as
necessary to account for potassium effects. The results confirm that
superexcitability decreases as serum potassium increases, and
indicate that potassium currents are more sensitive to external
potassium than the present model predicts. A new model is
proposed in which the potassium currents in human motor axons
depend on extracellular potassium as if 1:1 binding of potassium
ions to the outside of the channel were necessary for their function,
a suggestion earlier made to account for the effects of altered
potassium concentrations on single myelinated axons of the frog
[19].
Methods
Ethics statement
All procedures were approved by the local ethical committee:
Kantonale Ethikkommission, Bern, Switzerland (KEK-Nr. 180/
10), and conformed to the Declaration of Helsinki. Experimental
procedures were fully explained and all subjects gave their written
informed consent to participate.
Subjects
Forty healthy volunteers were enrolled to participate in this
study. There were 23 women and 17 men, aged between 21 and
79 years. None of the subjects suffered from carpal tunnel
syndrome or had any history of a neuromuscular disorder or any
risk factor for peripheral neuropathy (including diabetes, neuro-
toxic medication and alcohol abuse). Finally, subjects with
abnormal potassium serum or creatinine were not included.
Normal ranges were defined as follows: serum potassium [3.5–
4.7 mmol/l] and creatinine [women: 45–84 mmol/l; men: 59–
104 mmol/l].
Laboratory examination
Subjects were comfortably rested on a bed in a warm room. A
5 ml blood sample was taken from one arm and the rest of the
examination was performed on the other side. Serum levels of
potassium and creatinine were measured. Serum creatinine was
used as marker of normal renal function [20].
Peripheral nerve excitability
Excitability properties of the peripheral nerve were assessed by
means of Qtrac software (copyright Institute of Neurology,
London, UK), as previously reported [2]. Since temperature
affects some excitability parameters [21], cutaneous temperature
was carefully monitored and maintained above 32uC through the
entire session.
Multiple measures of nerve excitability were performed on the
median motor nerve at the wrist, using surface electrodes, as
previously described [2,22,23]. Electrical stimuli were applied via
non-polarizable electrodes (Red Dot, 3 M Health Care, Borken,
Germany), the cathode being placed on the median nerve at the
wrist and the anode being placed about 10 cm proximal, over the
muscle. Stimulus waveforms generated by a computer were
converted to current with a purpose-built isolated linear bipolar
constant current stimulator (DS5, Digitmer Ltd., Welwyn Garden
City, UK) (maximum output 50 mA).
Compound muscle action potentials (CMAP) were recorded
from abductor pollicis brevis (APB), using adhesive disposable
surface electrodes (REF 9013L0203, Alpine BioMed, Skovlunde,
Denmark) with the active electrode at the motor point and the
reference electrode on the proximal phalanx. The ground
electrode (Red Dot surface electrode) was taped on the top of
the hand. The signal was amplified (gain: 1000, bandwidth: 1.6–
2 kHz) and digitized with a data acquisition unit (National
Instruments NI DAQCARD-6062E, National Instruments Europe
Corp., Debrecen, Hungary) using a sampling rate of 10 kHz.
Nerve excitability measurements were made using the
TRONDNF protocol. Initially the 1 ms stimulus was set manually
to a supramaximal level, and then the computer generated a
stimulus-response relationship by progressively decreasing the
strength of the stimulus in 2% steps. Next, computer feedback was
used to track the stimulus that excited a CMAP equal to 40% of
maximal amplitude and threshold comparisons were used to
evaluate strength-duration curve, threshold electrotonus, current-
threshold (I/V) relationship and recovery cycle. For the strength-
duration relationship, the threshold current required to generate
the target CMAP was tracked as the pulse duration was reduced
from 1 ms to 0.2 ms. During threshold electrotonus, excitability
was tested at 26 intervals during and after 100 ms polarizing
currents set to 620% and 640% of the control threshold current.
For the I/V relationship, excitability was tested after 200 ms
current pulses that were varied from 50% to 2100% of control
threshold, in 10% steps. Finally, for the recovery cycle, excitability
was tested at 18 inter-stimulus intervals (ISI) from 200 ms to 2 ms
after a supra-maximal conditioning stimulus.
Data analysis
The nerve excitability data were analyzed by means of the
QtracP program, as previously described [2]. Multiple excitability
measure files were generated for each recording. These files
contained all the threshold estimates (e.g. for 26 time points on the
threshold electrotonus), and also a set of derived excitability
measurements that was retained for analysis:
i) from the strength-duration relationship: strength-duration
time constant and rheobase
ii) from the threshold electrotonus: mean threshold reductions
between the specified times after the start of polarization, for the
40% depolarizing current (TEd40[10–20 ms], TEd40[90–
100 ms]), the 20% depolarizing current (TEd20[10–20 ms],
TEd20[90–100 ms]), the 20% hyperpolarizing current
(TEh20[10–20 ms], TEh20[90–100 ms]), and for the 40%
hyperpolarizing current (TEh40[10–20 ms], TEh40[90–
100 ms]). Also, the maximal threshold reductions were measured
for the 40% and 20% depolarizing currents (TEd40[peak],
TEd20[peak]).
iii) from the I/V relationship: resting and minimum I/V slope
(an analogue of conductance)
iv) from the recovery cycle: refractoriness, superexcitability and
late subexcitability.
Statistical analysis
All data are reported as mean 6SD. Correlations were assessed
by the Pearson product moment correlation coefficient R. The
level of significance was set at P,0.05.
Nerve models
The dependence of nerve excitability properties on extracellular
potassium was modelled in 3 different ways:
Model 1. The first model was the human motor axon model
described in detail by Howells et al.[17]. In this model, potassium
and leakage channels are modelled as conductances, as in the
original Hodgkin-Huxley model of the squid giant axon, and the
first model of human nodal membrane currents [24], e.g.
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IKf~GKf :n
4(E{EK ) ð1Þ
where IKf is the fast potassium current, GKf is the maximum fast
potassium conductance (a constant), n is the fraction of activated
gates, E is the membrane potential, and EK is the reversal potential
for potassium currents, given by the Nernst equation: EK = RT/F
6 ln([K]o/[K]i). Similarly,
IKs~GKs:s(E{EK ) ð2Þ
where IKs is the slow potassium current and s is the fraction of
activated channels, and
ILk~GLk(E{Er) ð3Þ
where ILk is the leakage current, GLk the leak conductance, and Er
is the resting potiential. Equations (1)–(3) are written separately for
the nodal and internodal axon membrane. In this model, changes
in extracellular potassium only affect potassium currents through
their effects on the potassium reversal potential EK.
Model 2. To allow for the fact that potassium ions more
readily diffuse from a region of high concentration to one of low
concentration than vice versa, the potassium currents can alterna-
tively be modelled by the constant field equation, as used by
Frankenhaeuser and Huxley to account for the potential
dependence of the nodal potassium currents of Xenopus laevis
[25]. In this formulation, potassium conductances (GK) are
replaced by potassium permeabilities (PK), and equations (1) and
(2) are replaced by equations (4) and (5) respectively:
IKf~PKf :n
4:EF
2
RT
K½ x ð4Þ
IKs~PKs:s:
EF2
RT
K½ x ð5Þ
where F, R and T are Avogadro’s number, the gas constant and
absolute temperature, respectively, and
K½ x~
K½ o{ K½ 
i:e
EF=RT
 
1{eEF=RT
ð6Þ
Model 3. Dubois [26] found that for both fast and slow
potassium currents at voltage-clamped frog nodes there was a
linear relationship between 1/GK and 1/[K]o at low values of
[K]o, consistent with channel opening being dependent on a 1:1
Figure 1. Multiple excitability measurements recorded from normal subjects: motor axons in the median nerve were tested at the
wrist and compound muscle action potentials recorded from the abductor pollicis brevis muscle. A–C: Mean +/2 SD for all 38 subjects.
D–F: Comparisons between means of Lower K (grey) and Higher K (black) groups. A, D: Threshold electrotonus, i.e., threshold changes during and
after polarizing currents set to +40 (top), +20,220 and240% (bottom) of threshold. B, E: Recovery cycle showing successive phases of refractoriness,
superexcitability, and late subexcitability. C,F: Current-threshold (I/V) relationship.
doi:10.1371/journal.pone.0098262.g001
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binding with extracellular K+ ions [19]. When [K]o is small, as it is
in vivo, potassium currents therefore become almost directly
proportional to [K]o, and this relationship was represented in
Model 3 by multiplying [K]x in equations (4) and (5) of Model 2 by
the factor [K]o/(average [K]o).
Model fitting procedure. The fitting of the models to the
nerve excitability data was performed with the MEMFIT facility
in QtracP, which minimizes the ‘discrepancy’ (D), scored as the
weighted mean of the error terms: ([xm - xn]/sn)
2, where xm is the
threshold of the model, xn is the mean, and sn is the standard
deviation of the thresholds for the real nerves. To keep the D
values consistent in this study, the sn values were always based on
the 14 medium K subjects (see below). The weights were the same
for all thresholds of the same type (e.g. recovery cycle) and were
chosen to give total weights to the four different types of threshold
measurement: threshold electrotonus, current–threshold relation,
recovery cycle, and strength–duration properties in the ratio
2:1:1:0.5. Parameter values for Model 1 were obtained from the
recently described model [17] by minimizing the discrepancy
between the model and the average of the data from the 38
subjects with an iterative least squares procedure, until alteration
of any of the membrane parameters would make the discrepancy
worse. For Model 2, starting values of the potassium permeabilities
were estimated by making each channel contribution to the resting
current the same as in model 1, then the iterative procedure was
repeated until the discrepancy was again minimized. Parameter
values for Model 3 were the same as for model 2.
Results
All subjects participated in the study without any adverse effects
and none of them requested an early termination of the recording
session. However, two subjects had potassium levels outside the
normal range (3.1 and 3.4 mmol/l) and were therefore excluded
from analysis. Potassium serum levels in the remaining 38 subjects
varied from 3.5 to 4.5 mmol/l (average concentration:
4.1160.25 mmol/l). The subjects were divided into 3 groups on
the basis of these potassium levels: Lower K (3.5–3.9, mean
3.82 mmol/l, n = 11); Medium K (4.0–4.2, mean 4.06 mmol/l,
n = 14) and Higher K (4.3–4.5, mean 4.39 mmol/l, n = 13). (It
should be emphasized that the 3 groups were all within the normal
range of 3.5 to 4.7 mmol/l.). Creatinine values were also all within
the normal ranges, and varied from 57 to 80 mmol/l (average:
69.4 mmol/l) in women and from 62 to 100 mmol/l (average:
83.2 mmol/l) in men. Average cutaneous temperature at the
stimulation site was 32.9260.73uC. The potassium levels in the
subjects were not correlated with age (Pearson R=0.141,
P=0.40), temperature (R=0.247, P=0. 14) or sex (R=0.018,
P=0.88). However, comparing the younger subjects (14 under 30)
with the older ones (24 over 30), although the mean potassium
levels were similar in the two age groups (younger 4.0960.18,
Figure 2. Examples of nerve excitability measures showing significant relationship to serum potassium levels. A: Superexcitability, B:
TEd20(90–100 ms) threshold decrease at end of 20% depolarizing current, C,D: TEh20(90–100 ms) and TEh40(90–100 ms) threshold decrease at end
of 20% and 40% hyperpolarizing current (NB Negative threshold decrease indicates threshold were increased by hyperpolarization).
doi:10.1371/journal.pone.0098262.g002
Serum K and Nerve Excitability
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older 4.1160.29 mmol/l, Welch test P=0.79), the variance of the
potassium levels was higher in the older group (F test P=0.034).
Nerve excitability and relation to serum potassium level
Nerve excitability waveforms recorded from the median motor
nerve are illustrated in Figure 1 for the 38 subjects. In the top row
are plotted the mean waveforms for the 38 subjects 61 SD. These
recordings are very similar to previously published normal
median/APB recordings [2]. In the bottom row the mean
recordings from the Lower K group are compared with those
from the Higher K group. Conventional excitability measure-
ments derived from the waveforms are listed in Table 1, with their
correlation to the serum potassium values. As previously reported
by Kuwabara and colleagues [18], there was a significant tendency
for axons to become less superexcitable at higher potassium levels
(R= 0.39, P=0.016). There was a clear tendency for electrotonus
to ‘fan in’ at higher potassium levels (i.e. TEd values to decrease,
TEh values to increase, Table 1 and Figure 2). Over this limited
potassium range, there was no significant dependence of rheobase
or strength-duration time constant on potassium.
Comparison with Models 1–3
Figure 3 shows electrotonus and recovery cycle waveforms
generated by the three models for potassium concentrations equal
to the Lower K (3.82 mmol/l) and Higher K (4.39 mmol/l)
groups, which can be compared with the recordings in Figures 1D
and 1E. Only Model 3 shows an increase in superexcitability at
lower potassium levels and fanning-out of depolarising as well as
hyperpolarising threshold electrotonus as seen in the recordings.
To further explore the potassium dependence of nerve
excitability according to the 3 models, and how they predict
extrapolation to hyperkalaemic levels, Figure 4 shows 2 excitability
measures plotted as a function of potassium concentration, and
compares the 3 models with the 3 groups of normal subjects, and
also with the previously published data for patients with chronic
renal failure, who had varying degrees of hyperkalemia prior to
dialysis [9]. In Figure 4A it can be seen that only Model 3 predicts
a marked reduction in superexcitability with increasing potassium,
and when model 3 is extrapolated to abnormally high potassium
levels, it predicts quite accurately the relationship previously found
in patients with renal failure prior to dialysis, as indicated by the
ellipse. The changes in electrotonus with potassium were too small
to distinguish between the models as far as the normal subjects are
concerned, but Fig 4B indicates that the changes in depolarizing
electrotonus (TEd40[90–100 ms]) in the renal failure patients with
hyperkalemia are also best explained by model 3.
Model 3 also provided the best fits taking into account all the
excitability measurements (i.e. current-voltage and charge-dura-
tion relationships as well as threshold electrotonus and recovery
cycle) as judged by the discrepancy scores D (see Methods for
Table 1.Mean values of excitability parameters derived from the multiple measures of nerve excitability performed on the median
nerve in 38 normal subjects.
Mean ±SD R v. [K]o P
Strength-duration relationship
SDTC (ms) 0.4760.14 0.187 0.27
Rheobase (mA) 3.8462.05 0.079 0.65
Depolarizing threshold electrotonus
TEd40[10–20 ms] (%) 69.565.8 20.364 0.024*
TEd40[peak](%) 68.765.7 20.348 0.030*
TEd40[90–100 ms] (%) 46.264.5 20.254 0.12
TEd20[10–20 ms](%) 36.764.5 20.318 0.049*
TEd20[peak] (%) 39.563.4 20.341 0.035*
TEd20[90–100 ms] 28.863.2 20.489 0.0019**
Hyperpolarizing threshold electrotonus
TEh20[10–20 ms] (%) 238.363.6 0.429 0.0070**
TEh20[90–100 ms] (%) 249.568.8 0.536 0.00061***
TEh40[10–20 ms] (%) 275.865.9 0.480 0.0024**
TEh40[90–100 ms] (%) 2124.1621.6 0.493 0.0018**
Current-threshold relationship
Resting I/V slope 0.59760.105 0.529 0.00073***
Minimum I/V slope 0.24660.050 0.097 0.57
Recovery cycle
RRP (ms) 2.8860.34 0.482 0.0023**
Superexcitability (%) 224.767.7 0.387 0.016*
Late Subexcitability (%) 14.164.7 20.145 0.39
First column shows mean 6 standard deviation (SD). Second column shows Pearson product moment correlation coefficient between excitability measure and serum
potassium. Third column shows p values (* = P,0.05, ** = P,0.01, *** = P,0.001). SDTC: strength-duration time constant. TEd20 and TEh20: threshold electrotonus
changes due to depolarizing and hyperpolarizing currents respectively, set to 20% of control threshold; TEd40, TEh40 same, but for 40% polarizing currents; expressions
in square brackets indicate times after start of 100 ms current, early [10–20 ms], late [90–100 ms] or around peak threshold change [ peak]. I/V: current-threshold. RRP:
relative refractory period.
doi:10.1371/journal.pone.0098262.t001
Serum K and Nerve Excitability
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definition). The mean data for the Medium K group could be
fitted well by either the constant conductance or constant
permeability models (D= 0.094 and 0.104 respectively). Without
allowance for the differences in potassium, the fits to the Lower K
and Higher K group recordings were, not surprisingly, worse
(D= 0.412, 0.419 respectively, Table 2). When allowance for the
differences in potassium were made according to Model 1, the fits
were improved by 14.1% for the Higher K group, but actually
made 1.5% worse for the lower K group. Model 2 produced better
fits, and Model 3 the best fits, with a reduction in discrepancy of
63.2% for the Higher K group, just by changing the [K+]o value
from 4.06 to 4.39. Although the discrepancy scores were
Figure 3. Threshold electrotonus (top row) and recovery cycle (bottom row) waveforms generated by Models 1–3 for values of
extracellular potassium corresponding to the Lower K (grey) and Higher K (black) groups.
doi:10.1371/journal.pone.0098262.g003
Figure 4. Potassium dependence of 2 nerve excitability measurements predicted by Models 1 (red line), 2 (green line) and 3 (blue
line) compared with mean measurements for Higher K (m), Medium K (N) and Lower K (&) groups, and ellipse representing 1 SD
limits for 9 patients with chronic renal failure (reproduced from Kiernan et al.).9 Only Model 3 predicts an appropriate drop in
superexcitability with increasing potassium level.
doi:10.1371/journal.pone.0098262.g004
Serum K and Nerve Excitability
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appreciably higher for the patients with chronic renal failure (who
had serum potassium values ranging from 4.3 to 6.1 mmol/l), the
discrepancy reductions obtained by the different ways of modelling
the effects of the hyperkalemia were similar to those obtained for
the Higher K normal subjects (Table 2).
In addition to the Models 1, 2 and 3, we have also explored the
consequences of other assumptions about the effects of changes in
[K]o, for example a constant conductance model with conduc-
tances proportional to [K]o, and permeability models with only
fast potassium channel permeability or slow potassium channel
permeability proportional to [K]o. These alternative models
produced results intermediate between Model 2 and Model 3.
Thus Model 3 provided the best simulation of the potassium
dependence of both the normal nerves recorded in this study and
also the earlier recordings from patients with chronic renal failure.
Discussion
This study has shown that even within a narrow range of
normal serum potassium levels (3.5–4.5 mmol/l), potassium has a
significant effect on nerve excitability properties, including super-
excitability and the responses to depolarizing and hyperpolarizing
currents as measured by threshold electrotonus. In this we have
confirmed a previous study by Kuwabara and colleagues [18],
using a somewhat different protocol in which 12 normal subjects
were each tested on 3 occasions, and in which there was a wider
range of potassium levels (3.5–5.0 mmol/l). The principle new
finding of this study is that the current model of human nerve
excitability cannot account for these relationships. To overcome
this deficiency we have presented a new model, in which
potassium currents are not only dependent on membrane
potential, but also proportional to extracellular potassium
concentration. Here we first relate these findings to previous
evidence about the potassium dependence of axonal potassium
currents, and then consider the implications for future nerve
excitability studies.
Potassium dependence of potassium currents
The dependence on external potassium concentration of
potassium currents in frog nodes was studied in detail by Dubois
and Bergman [19]. They concluded that the potassium conduc-
tance (gK) behaved as if proportional to 1:1 binding of external K
+
ions to membrane sites, i.e. gK = GK.[K]o/(Kapp + [K]o), where
GK is the maximum conductance when all sites are occupied, and
Kapp is the apparent dissociation constant. Kapp depended on
membrane potential and external calcium concentration, but was
sufficiently high in the physiological region of excitability studies
that gK was effectively directly proportional to [K]o. The notion of
an external binding site was strengthened by the finding that
external caesium ions could replace potassium ions in enabling
outward potassium currents, so long as their concentration was
kept low [19]. That study was re-evaluated by Dubois [26] in the
light of his evidence for 3 different types of potassium channel. He
concluded that the apparent voltage dependence of Kapp in the
earlier study was attributable to the existence of different
potassium channels with different voltage dependence, and that
potassium conductance increased with [K]o for both fast and slow
potassium channels.
The question of the potassium dependence of potassium
currents has received little attention in mammalian myelinated
axons. The first nodal voltage clamp studies of rabbit and rat fibers
[27,28] found potassium currents to be almost non-existent,
because the fast potassium channels are mainly restricted to the
juxta-paranodal region, under the myelin sheath [29,30]. While
later studies of mammalian, including human, nodal ion currents
have recognized the importance of slow as well as fast potassium
currents [24,31,32] the dependence of these currents on external
potassium concentrations within the physiological range has never,
so far as we are aware, been investigated. Single channel patch
clamp studies have found higher unitary channel currents in the
high [K]o solutions commonly used than in Ringer solution (e.g. 18
ps v. 10 ps for outward ‘I channel’ potassium currents) [33], but
possible effects of [K]o on open channel probability have not been
described. The present study provides evidence that the potassium
channels in human myelinated axons are critically dependent on
extracellular potassium, as in the frog.
Implications for nerve excitability studies
Nerve excitability studies can provide a considerable amount of
information about altered nerve membrane properties in disease,
but the evidence they provide is indirect and it has sometimes only
been by modelling the excitability changes that interpretation has
been possible (e.g. the effects of sodium channel block by
tetrodotoxin) [3]. It is therefore important to ensure that the
model can correctly take account of alterations in the nerve milieu,
such as potassium concentration, with effects on excitability. In the
case of patients with renal failure, the very high correlations found
between excitability changes (including superexcitability) and
serum potassium levels, provided good evidence of a strong causal
connection [9,10]. Very recently, a causal connection has been
proved more decisively by an elegant, two-stage dialysis procedure,
in which the serum potassium level was kept constant for the first
Table 2. Comparison between the three models in their ability to account for the effects of changes in serum potassium levels on
multiple measures of nerve excitability.
Lower K+ Higher K+ High K+
normal subjects (n=11) normal subjects (n=13) CRF patients * (n=9)
Medium [K+]o (mmol/l) 3.82 4.39 5.02
Discrepancy from Medium K data (n = 14) 0.412 0.419 3.85
Discrepancy from Model 1 (% reduction) 0.418 (21.5%) 0.360 (14.1%) 3.503 (9.0%)
Discrepancy from Model 2 (% reduction) 0.368 (10.7%) 0.259 (38.2%) 2.545 (33.9%)
Discrepancy from Model 3 (% reduction) 0.243 (41.0%) 0.154 (63.2%) 1.218 (68.4%)
Data from Medium K data was fitted to nerve model, and then adjusted for different potassium levels according to Models 1, 2 and 3. Discrepancies score difference
between model and recorded data and discrepancy reductions score improvement over no allowance for potassium. For each data set Model 3 provides lowest
discrepancy (figures in bold).
doi:10.1371/journal.pone.0098262.t002
Serum K and Nerve Excitability
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3 hours [13]. However, the authors observed that the available
model of human motor nerve excitability could not account well
for the relationship between serum potassium concentration and
excitability properties, especially superexcitability, and suggested
that the hyperkalaemia might also be disrupting the myelin sheath.
However, our new evidence clearly shows that that model is
inadequate to account for the effects of potassium on nerve
excitability, even in normal control subjects with potassium levels
in the normal range. A better model is required, and the new
model presented here provides a simple explanation of how
hyperkalemia alone can be responsible for the superexcitability
changes in uremia (as illustrated by the ellipse in Fig. 4A) as well as
for the dependence of superexcitability on potassium in normal
subjects.
The other important lesson of this study is to reinforce the
conclusions of Kuwabara et al. [17] that excitability studies should
be performed when serum potassium levels are stable (e.g. before a
meal), and where possible a blood sample should be taken at the
same time for electrolyte analysis. Model 3 (which is now
incorporated in the Qtrac software) provides a means for
predicting the likely contribution of serum potassium level to the
nerve excitability measurements.
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